Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predicting inflammatory bowel disease in children with abdominal pain and diarrhoea: calgranulin-C versus calprotectin stool tests.
Heida A, Van de Vijver E, van Ravenzwaaij D, Van Biervliet S, Hummel TZ, Yuksel Z, Gonera-de Jong G, Schulenberg R, Muller Kobold A, van Rheenen PF; CACATU consortium. Heida A, et al. Among authors: hummel tz. Arch Dis Child. 2018 Jun;103(6):565-571. doi: 10.1136/archdischild-2017-314081. Epub 2018 Mar 7. Arch Dis Child. 2018. PMID: 29514815 Free PMC article.
Adalimumab therapy in children with Crohn disease previously treated with infliximab.
Cozijnsen M, Duif V, Kokke F, Kindermann A, van Rheenen P, de Meij T, Schaart M, Damen G, Norbruis O, Pelleboer R, Van den Neucker A, van Wering H, Hummel T, Oudshoorn J, Escher J, de Ridder L; Dutch PIBD Working Group Kids with Crohn and Colitis. Cozijnsen M, et al. J Pediatr Gastroenterol Nutr. 2015 Feb;60(2):205-10. doi: 10.1097/MPG.0000000000000589. J Pediatr Gastroenterol Nutr. 2015. PMID: 25286063
The prevalence of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease, and the relationship with biochemical markers of disease activity.
Diederen K, Hoekman DR, Hummel TZ, de Meij TG, Koot BG, Tabbers MM, Vlieger AM, Kindermann A, Benninga MA. Diederen K, et al. Among authors: hummel tz. Aliment Pharmacol Ther. 2016 Jul;44(2):181-8. doi: 10.1111/apt.13636. Epub 2016 Apr 25. Aliment Pharmacol Ther. 2016. PMID: 27110920 Free article.
Efficacy of Home Telemonitoring versus Conventional Follow-up: A Randomized Controlled Trial among Teenagers with Inflammatory Bowel Disease.
Heida A, Dijkstra A, Muller Kobold A, Rossen JW, Kindermann A, Kokke F, de Meij T, Norbruis O, Weersma RK, Wessels M, Hummel T, Escher J, van Wering H, Hendriks D, Mearin L, Groen H, Verkade HJ, van Rheenen PF. Heida A, et al. J Crohns Colitis. 2018 Mar 28;12(4):432-441. doi: 10.1093/ecco-jcc/jjx169. J Crohns Colitis. 2018. PMID: 29228230 Clinical Trial.
First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn's disease: an open-label multicentre randomised controlled trial.
Jongsma MME, Aardoom MA, Cozijnsen MA, van Pieterson M, de Meij T, Groeneweg M, Norbruis OF, Wolters VM, van Wering HM, Hojsak I, Kolho KL, Hummel T, Stapelbroek J, van der Feen C, van Rheenen PF, van Wijk MP, Teklenburg-Roord STA, Schreurs MWJ, Rizopoulos D, Doukas M, Escher JC, Samsom JN, de Ridder L. Jongsma MME, et al. Gut. 2022 Jan;71(1):34-42. doi: 10.1136/gutjnl-2020-322339. Epub 2020 Dec 31. Gut. 2022. PMID: 33384335 Free PMC article. Clinical Trial.
24 results